|
DE2334009A1
(de)
*
|
1973-07-04 |
1975-01-23 |
Boehringer Mannheim Gmbh |
Purin-derivate sowie verfahren zu ihrer herstellung
|
|
DE2401254A1
(de)
*
|
1974-01-11 |
1975-11-27 |
Boehringer Mannheim Gmbh |
Neue derivate von n hoch 6-substituierten adeninen
|
|
US3957994A
(en)
*
|
1974-12-19 |
1976-05-18 |
Nelson Research & Development Company |
Topical anti-inflammatory composition and method of use
|
|
FR2303551A1
(fr)
*
|
1975-03-12 |
1976-10-08 |
Brun Lab Sa Le |
Derives de la 8-amino theophylline, leur procede de preparation et leurs applications
|
|
FR2527608B1
(fr)
*
|
1982-05-28 |
1986-10-10 |
Sandoz Sa |
Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments
|
|
HU198052B
(en)
*
|
1986-02-14 |
1989-07-28 |
Sandoz Ag |
Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds
|
|
US5057517A
(en)
*
|
1987-07-20 |
1991-10-15 |
Merck & Co., Inc. |
Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
|
|
KR100239800B1
(ko)
*
|
1996-11-28 |
2000-03-02 |
손경식 |
4,5-디아미노 피리미딘 유도체 및 이의 제조방법
|
|
IT1293804B1
(it)
|
1997-08-01 |
1999-03-10 |
Recordati Chem Pharm |
Diarilalchilpiperazine attive sulle basse vie urinarie
|
|
US6825198B2
(en)
*
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
US7129239B2
(en)
*
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
|
US8076338B2
(en)
*
|
2004-04-23 |
2011-12-13 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
GB0412072D0
(en)
*
|
2004-05-28 |
2004-06-30 |
Syngenta Participations Ag |
Chemical compounds
|
|
WO2014086453A1
(en)
*
|
2012-12-07 |
2014-06-12 |
Merck Patent Gmbh |
Azaheterobicyclic compounds
|
|
WO2016030443A1
(en)
*
|
2014-08-28 |
2016-03-03 |
Asceneuron Sa |
Glycosidase inhibitors
|
|
US11261183B2
(en)
|
2016-02-25 |
2022-03-01 |
Asceneuron Sa |
Sulfoximine glycosidase inhibitors
|
|
CA3012624A1
(en)
|
2016-02-25 |
2017-08-31 |
Asceneuron S.A. |
Glycosidase inhibitors
|
|
US11612599B2
(en)
|
2016-02-25 |
2023-03-28 |
Asceneuron Sa |
Glycosidase inhibitors
|
|
IL260638B2
(en)
|
2016-02-25 |
2025-01-01 |
Asceneuron S A |
Acidic addition salts of piperazine derivatives
|
|
US11213525B2
(en)
|
2017-08-24 |
2022-01-04 |
Asceneuron Sa |
Linear glycosidase inhibitors
|
|
WO2020039028A1
(en)
|
2018-08-22 |
2020-02-27 |
Asceneuron S. A. |
Tetrahydro-benzoazepine glycosidase inhibitors
|
|
BR112021003022A2
(pt)
|
2018-08-22 |
2021-05-11 |
Asceneuron Sa |
sais de adição de ácido de ácido succínico ou ácido fumárico, de ácido monossuccínico, de ácido monofumárico e de adição de ácido succínico ou sal de adição de ácido fumárico, métodos para preparar um sal de adição de ácido do ácido succínico ou ácido fumárico, para tratar uma tauopatia e para inibir uma glicosidase, e, forma de dosagem oral sólida
|
|
US12016852B2
(en)
|
2018-08-22 |
2024-06-25 |
Asceneuron Sa |
Pyrrolidine glycosidase inhibitors
|
|
US11731972B2
(en)
|
2018-08-22 |
2023-08-22 |
Asceneuron Sa |
Spiro compounds as glycosidase inhibitors
|